Therapeutic Advances in Infectious Disease
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.8 | Q2 | 71.6% | 0.948 | Q2 | 82.5% |
| 2024 | 3.4 | Q2 | 72.3% | 1.197 | Q1 | 88.3% |
| 2023 | 3.8 | Q2 | 76.4% | 1.015 | Q1 | 85.8% |
| 2022 | 5.7 | 83.0% | 1.341 | Q1 | 91.6% | |
| 2021 | — | 39.6% | 0.633 | Q2 | 74.5% | |
| 2020 | — | — | — | 0.0% | ||
| 2019 | — | — | — | 0.0% | ||
| 2018 | — | — | — | 0.0% | ||
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2049-9361
ISSN
2049-937X
country
GBcoverage
2013-2026